Handelsbanken Fonder’s Amneal Pharmaceuticals AMRX Stock Holding History

Handelsbanken Fonder’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	76,400 +2,200	+3%	+$30.1K	﹤0.01%	1009
2026 Q1	$922K	Buy	74,200 +20,300	+38%	+$273K	﹤0.01%	1077
2025 Q4	$679K	Buy	53,900 +14,900	+38%	+$170K	﹤0.01%	1202
2025 Q3	$390K	Hold	39,000	–	–	﹤0.01%	1356
2025 Q2	$316K	Hold	39,000	–	–	﹤0.01%	1411
2025 Q1	$327K	Hold	39,000	–	–	﹤0.01%	1377
2024 Q4	$309K	Buy	+39,000	New	+$327K	﹤0.01%	1446
2023 Q2	–	Sell	-42,274	Closed	-$59K	–	1569
2023 Q1	$59K	Hold	42,274	–	–	﹤0.01%	1545
2022 Q4	$84K	Hold	42,274	–	–	﹤0.01%	1528
2022 Q3	$85K	Hold	42,274	–	–	﹤0.01%	1537
2022 Q2	$134K	Hold	42,274	–	–	﹤0.01%	1553
2022 Q1	$176K	Hold	42,274	–	–	﹤0.01%	1647
2021 Q4	$202K	Hold	42,274	–	–	﹤0.01%	1707
2021 Q3	$226K	Hold	42,274	–	–	﹤0.01%	1640
2021 Q2	$216K	Buy	42,274 +23,400	+124%	+$133K	﹤0.01%	1688
2021 Q1	$127K	Hold	18,874	–	–	﹤0.01%	1555
2020 Q4	$86K	Hold	18,874	–	–	﹤0.01%	1543
2020 Q3	$73K	Hold	18,874	–	–	﹤0.01%	1449
2020 Q2	$90K	Buy	+18,874	New	+$77.7K	﹤0.01%	1429

Other funds holding AMRX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

SFGP

Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.32B AUM 23.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder's AMRX Position: Q2 2026 in Review

Handelsbanken Fonder increased its Amneal Pharmaceuticals (AMRX) stake by 3% in Q2 2026, buying an estimated $30.1K and bringing the position to 76,400 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Handelsbanken Fonder first reported a position in AMRX in Q2 2020 and has held it in 19 quarters since. 27 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Handelsbanken Fonder held 76,400 shares of Amneal Pharmaceuticals worth $1.32M as of Q2 2026.
Handelsbanken Fonder bought 2,200 Amneal Pharmaceuticals shares in Q2 2026, an estimated $30.1K.
Amneal Pharmaceuticals made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1009 holding.
Handelsbanken Fonder first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
27 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.